Whitehall-Robins' vitamin/mineral/herbal combination product increases levels of plasma vitamin E, folic acid and vitamin B12, M.H. Davidson, Chicago Center for Clinical Research, et al., report in poster to be presented at Federation of American Societies for Experimental Biology meeting in Orlando, Fla. March 31 to April 4. Results of the 12-week, double-blind, placebo-controlled study involving 161 people indicate "key nutrients are well absorbed from this formulation, which improved cardiovascular risk factors [such as] elevated homocysteine and low density lipoprotein susceptibility to oxidation," researchers conclude. Homocysteine levels decreased 17.2% in active arm compared to mean increase of 3.2% in placebo arm. Centrum Heart Focused Formula contains vitamins B6, B12 and E, folate, selenium, manganese, garlic powder, taurine and coenzyme Q10. Study was funded in part by Whitehall-Robins
Join thousands of industry professionals who rely on Pink Sheet for daily insights
Already a subscriber?
Advanz Pharma would have had to show that the European Commission’s decision to revoke Ocaliva’s conditional marketing approval risked causing serious and irreparable harm, according to lawyers from Van Bael & Bellis.
This is your final call to participate in the survey to better understand our subscribers’ content and delivery needs. The deadline is 20 September.
We are conducting a survey to better understand our subscribers’ content and delivery needs. If there are any changes you’d like to see in coverage topics, article format, or the method in which you access the Pink Sheet – or if you love it how it is – now is the time to have your voice heard.
A new pilot aims to take Brazil closer to ‘digital transformation.’
Julian Beach, interim executive director of healthcare quality and access at the UK drug regulator, the MHRA, tells the Pink Sheet how the agency is responding to increased efforts to develop bacteriophage therapies.
Exclusive analysis by the Pink Sheet explores how non-submissions by pharmaceutical companies to England’s health technology appraisal body are impacting the availability of medicines on the National Health Service.
As South Korea's new president immediately gets to work on setting initial policies, essential drug supplies, R&D incentives and AI-driven digital healthcare are among the key topics in focus.
